☆ 4.6 Article

gamma-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus

WORLD JOURNAL OF GASTROENTEROLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Endocrinology & Metabolism

Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023

Nuha A. ElSayed et al.

DIABETES CARE (2023)

Add to Collection

Article Cell Biology

Cancer-cell-derived GABA promotes beta-catenin-mediated tumour growth and immunosuppression

De Huang et al.

Summary: Huang et al. report that cancer cells can rewire glutamine metabolism to synthesize the neurotransmitter GABA, which activates beta-catenin and suppresses T-cell infiltration, promoting tumor growth and leading to resistance to immune checkpoint blockade therapy. Targeting GAD1 or GABA(B)R can overcome this resistance and improve treatment outcomes.

NATURE CELL BIOLOGY (2022)

Add to Collection

Review Endocrinology & Metabolism

The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms

Bing Zhu et al.

Summary: There is an association between diabetes mellitus and certain cancers, with an increased risk of cancer in diabetes mellitus. Conversely, some cancers and cancer therapies may lead to diabetes mellitus. Genetic factors, obesity, inflammation, and other factors play a role in the crosstalk between diabetes mellitus and cancers.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Article Oncology

High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus

Charupong Saengboonmee et al.

Summary: The study demonstrates that high glucose can induce the expression of cell cycle machinery proteins in CCA cells, especially cyclin A, and that hyperglycemia is associated with significantly increased nuclear cyclin A levels in tumor tissues from CCA patients, leading to a shorter post-operative survival period of less than 5 months. Silencing cyclin A expression enhances the sensitivity of CCA cells to pan-CDKs inhibitors, suggesting a potential alternative treatment approach for CCA patients with diabetes mellitus.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2022)

Add to Collection

Review Oncology

Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis

Giuseppe Viscardi et al.

Summary: This study analyzed the incidence of early death (ED) in randomized clinical trials (RCTs) using immune checkpoint inhibitors. The results showed that the risk of ED was higher when immune checkpoint inhibitors were used alone compared to non-immune checkpoint inhibitor therapies, while the risk was lower when they were used in combination with other therapies. Patients with gastric cancer and urothelial carcinoma were at a higher risk of ED. PD-L1 expression and the class of immune checkpoint inhibitor drugs were not associated with ED.

EUROPEAN JOURNAL OF CANCER (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Nobiletin suppresses cholangiocarcinoma proliferation via inhibiting GSK3β

Liping You et al.

Summary: Nobiletin (NBT) has been found to inhibit the proliferation of cholangiocarcinoma (CCA) cells by directly binding to GSK3 beta. This suggests that NBT could be a potential natural medicine for the treatment of CCA.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

Add to Collection

Review Medicine, Research & Experimental

The role of glycogen synthase kinase 3 (GSK3) in cancer with emphasis on ovarian cancer development and progression: A comprehensive review

Mislav Glibo et al.

Summary: GSK3 is a key enzyme involved in various cellular processes, including cancer development. Its role in ovarian carcinoma is still controversial, with further research needed to fully understand its pathophysiological and clinical implications.

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2021)

Add to Collection

Review Endocrinology & Metabolism

Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication

Charupong Saengboonmee et al.

Summary: Diabetes mellitus is a risk factor for cancer and is associated with an increased risk of cholangiocarcinoma. The antidiabetic drug metformin is associated with a reduced risk of cholangiocarcinoma and inhibited progression. Different antidiabetic medications have varying effects on the development and progression of cholangiocarcinoma.

CANADIAN JOURNAL OF DIABETES (2021)

Add to Collection

Article Oncology

High glucose-ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8

Unchalee Thonsri et al.

Summary: The study demonstrated that high glucose conditions promote the progression of cholangiocarcinoma through ROS-mediated upregulation of MAN2A2 and CHD8. CHD8 regulates cell proliferation and migration by controlling the expression of MAN2A2.

CANCER SCIENCE (2021)

Add to Collection

Article Medicine, Research & Experimental

High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma

Marutpong Detarya et al.

Summary: High glucose promotes the progression of CCA cells by upregulating FOXM1 expression and activating EGFR/STAT3 pathways.

LIFE SCIENCES (2021)

Add to Collection

Review Oncology

Targeting FGFR inhibition in cholangiocarcinoma

Lipika Goyal et al.

Summary: CCAs, particularly iCCAs, often have therapeutic implications from somatic alterations such as FGFR2 fusions or rearrangements. Clinical trials for FGFR kinase inhibitors have shown consistent activity in previously treated iCCA patients with FGFR alterations, although differences in structure, mechanisms, and specificities remain to be fully characterized. Managing adverse events such as hyperphosphatemia and monitoring for acquired resistance are essential as FGFR inhibitors and other targeted agents are used in the clinic for FGFR-driven CCA.

CANCER TREATMENT REVIEWS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer

Alessandro Rizzo et al.

Summary: The paper provides an overview of current status of immunotherapies for biliary tract cancer (BTC), discusses the pharmacology, safety and efficacy of anti-PD-L1 inhibitor durvalumab in treating BTC, and considers future research directions for this agent in this context.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

Add to Collection

Article Infectious Diseases

Association of comorbidity between Opisthorchis viverrini infection and diabetes mellitus in the development of cholangiocarcinoma among a high-risk population, northeastern Thailand

Kavin Thinkhamrop et al.

Summary: The combination of Opisthorchis viverrini infection and diabetes mellitus is highly associated with cholangiocarcinoma, with a combined effect greater than either condition alone. This suggests that cholangiocarcinoma screening should prioritize individuals with both Opisthorchis viverrini infection and diabetes mellitus.

PLOS NEGLECTED TROPICAL DISEASES (2021)

Add to Collection

Review Medicine, General & Internal

Baclofen therapeutics, toxicity, and withdrawal: A narrative review

Jia W. Romito et al.

Summary: Baclofen is an effective therapeutic for various disorders, but comes with potential complications that require prompt recognition and management.

SAGE OPEN MEDICINE (2021)

Add to Collection

Review Multidisciplinary Sciences

Molecular mechanisms of metabotropic GABAB receptor function

Hamidreza Shaye et al.

Summary: GABA(B) receptors play a crucial role in inhibitory neurotransmission in the brain, modulating neuronal signaling and being linked to various neurological disorders. Recent cryo-EM studies have provided detailed insights into the activation mechanism of GABA(B) receptors, offering potential for the discovery of new therapeutic drugs and neuromodulators. The structures of the receptor in different conformational states and bound to various ligands contribute to a comprehensive understanding of the receptor's activation process.

SCIENCE ADVANCES (2021)

Add to Collection

Review Gastroenterology & Hepatology

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis

Oliver Clements et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Cell Biology

Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient

Banchob Sripa et al.

HUMAN CELL (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The GABA(B)Receptor-Structure, Ligand Binding and Drug Development

Linn Samira Mari Evenseth et al.

MOLECULES (2020)

Add to Collection

Article Oncology

Diabetes and PKM2 affect prognosis in patients with intrahepatic cholangiocarcinoma

Kui Fu et al.

ONCOLOGY LETTERS (2020)

Add to Collection

Article Oncology

Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look

Angela Dalia Ricci et al.

CANCER CONTROL (2020)

Add to Collection

Article Medicine, Research & Experimental

NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells

Charupong Saengboonmee et al.

LIFE SCIENCES (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends

Moien Abdul Basith Khan et al.

JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2020)

Add to Collection

Review Oncology

Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers

Yves Lecarpentier et al.

FRONTIERS IN ONCOLOGY (2019)

Add to Collection

Article Infectious Diseases

Co-occurrence of opisthorchiasis and diabetes exacerbates morbidity of the hepatobiliary tract disease

Apisit Chaidee et al.

PLOS NEGLECTED TROPICAL DISEASES (2018)

Add to Collection

Article Pharmacology & Pharmacy

GABABR-Induced EGFR Transactivation Promotes Migration of Human Prostate Cancer Cells

Shuai Xia et al.

MOLECULAR PHARMACOLOGY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Add to Collection

Article Oncology

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

Apinya Jusakul et al.

CANCER DISCOVERY (2017)

Add to Collection

Article Multidisciplinary Sciences

High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation

Chatchai Phoomak et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Review Oncology

Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease

Alessandro Mantovani et al.

ANNALS OF TRANSLATIONAL MEDICINE (2017)

Add to Collection

Article Multidisciplinary Sciences

High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation

Charupong Saengboonmee et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Review Oncology

Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma Association of diabetes mellitus and cholangiocarcinoma

Charupong Saengboonmee et al.

CANCER EPIDEMIOLOGY (2015)

Add to Collection

Review Pharmacology & Pharmacy

GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation

Michelangelo Auteri et al.

PHARMACOLOGICAL RESEARCH (2015)

Add to Collection

Article Gastroenterology & Hepatology

STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression

Hasaya Dokduang et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)

Add to Collection

Review Oncology

STAT3 Target Genes Relevant to Human Cancers

Richard L. Carpenter et al.

CANCERS (2014)

Add to Collection

Article Gastroenterology & Hepatology

Gamma-Aminobutyric Acid Binds to GABAB Receptor to Inhibit Cholangiocarcinoma Cells Growth via the JAK/STAT3 Pathway

Qiang Huang et al.

DIGESTIVE DISEASES AND SCIENCES (2013)

Add to Collection

Article Gastroenterology & Hepatology

GABA Induces the Differentiation of Small Into Large Cholangiocytes by Activation of Ca2+/CaMK I-Dependent Adenylyl Cyclase 8

Romina Mancinelli et al.

HEPATOLOGY (2013)

Add to Collection

Article Genetics & Heredity

Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers

Waraporn Chan-on et al.

NATURE GENETICS (2013)

Add to Collection

Article Biochemistry & Molecular Biology

NCBI GEO: archive for functional genomics data sets-update

Tanya Barrett et al.

NUCLEIC ACIDS RESEARCH (2013)

Add to Collection

Article Oncology

Neurotransmitter γ-aminobutyric acid-mediated inhibition of the invasive ability of cholangiocarcinoma cells

Qiang Huang et al.

ONCOLOGY LETTERS (2011)

Add to Collection

Article Endocrinology & Metabolism

Diabetes and Cancer A consensus report

Edward Giovannucci et al.

DIABETES CARE (2010)

Add to Collection

Review Pharmacology & Pharmacy

A gut feeling about GABA: focus on GABA(B) receptors

Niall P. Hyland et al.

FRONTIERS IN PHARMACOLOGY (2010)

Add to Collection

Article Biochemistry & Molecular Biology

Differential regulation of STAT family members by glycogen synthase kinase-3

Eleonore Beurel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Add to Collection

Article Gastroenterology & Hepatology

Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma

Natini Jinawath et al.

HEPATOLOGY (2006)

Add to Collection

Article Gastroenterology & Hepatology

Identification of γ-aminobutyric acid receptor subunit types in human and rat liver

R Erlitzki et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.